BRIEF

on INNATE PHARMA (EPA:IPH)

Innate Pharma Announces 2024 Financial Results Conference

Stock price chart of INNATE PHARMA (EPA:IPH) showing fluctuations.

On March 20, 2025, Innate Pharma announced a conference call and webcast to present its 2024 financial results. The event will take place on March 27, 2025, at 2:00 PM CET. Speakers will include Jonathan Dickinson, Sonia Quaratino, Yannis Morel, and Frédéric Lombard, key executives of the company.

Event details are available on the Innate Pharma website, and a replay will be available for 90 days after the presentation. Attendees can register via a provided link to watch the conference by phone.

Innate Pharma specializes in cancer immunotherapy, with various key partnerships in the biopharmaceutical industry. The company, based in Marseille, is listed on Euronext Paris and Nasdaq.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all INNATE PHARMA news